Mucinous adenocarcinoma
MONDO:0004957An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.
Also known as: adenocarcinoma, mucinous, malignant, colloid adenocarcinoma, colloid carcinoma, gelatinous adenocarcinoma, gelatinous carcinoma, mucin-producing adenocarcinoma (morphologic abnormality), mucinous adenocarcinoma, mucinous carcinoma
2804 clinical trials for this condition and its sub-types, 18 tagged with Mucinous adenocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Mucinous adenocarcinoma
-
Colon mucinous adenocarcinoma 2 trials · 21 incl. sub-types
1 sub-type
- Mucinous adenocarcinoma of the appendix 4 trials · 19 incl. sub-types Sub-types →
-
Ovarian mucinous adenocarcinoma 11 trials · 14 incl. sub-types
1 sub-type
- Ovarian mucinous cystadenocarcinoma 4 trials
-
Mucinous cystadenocarcinoma 1 trial · 5 incl. sub-types
4 sub-types
- Ovarian mucinous cystadenocarcinoma 4 trials
- Appendix mucinous cystadenocarcinoma 0 trials
- Breast mucinous cystadenocarcinoma 0 trials
- Pancreatic mucinous cystadenocarcinoma 0 trials Sub-types →
-
Endometrial mucinous adenocarcinoma 2 trials
-
Mucoepidermoid carcinoma 2 trials
12 sub-types
- Cutaneous mucoepidermoid carcinoma 0 trials
- Extrahepatic bile duct mucoepidermoid carcinoma 0 trials
- Lacrimal gland mucoepidermoid carcinoma 0 trials
- Laryngeal mucoepidermoid carcinoma 0 trials
- Mucoepidermoid breast carcinoma 0 trials
- Mucoepidermoid esophageal carcinoma 0 trials
- Oral cavity mucoepidermoid carcinoma 0 trials Sub-types →
- Paranasal sinus mucoepidermoid carcinoma 0 trials
- Pulmonary mucoepidermoid carcinoma 0 trials Sub-types →
- Thymic mucoepidermoid carcinoma 0 trials
- Thyroid gland mucoepidermoid carcinoma 0 trials
- Trachea mucoepidermoid carcinoma 0 trials
-
Breast mucinous carcinoma 1 trial
1 sub-type
-
Rectum mucinous adenocarcinoma 1 trial
1 sub-type
- Anal mucinous adenocarcinoma 0 trials
-
Cervical mucinous adenocarcinoma 0 trials · 1 incl. sub-types
6 sub-types
- Endocervical type cervical mucinous adenocarcinoma 1 trial
- Cervical mucinous adenocarcinoma, minimal deviation variant 0 trials
- Cervical villoglandular adenocarcinoma 0 trials
- Intestinal variant cervical mucinous adenocarcinoma 0 trials
- Signet ring cell variant cervical mucinous adenocarcinoma 0 trials
- Uterine ligament mucinous adenocarcinoma 0 trials
-
Colloid carcinoma of the pancreas 0 trials
-
3 sub-types
-
Gallbladder mucinous adenocarcinoma 0 trials
-
Lung colloid adenocarcinoma 0 trials
2 sub-types
-
Mucinous gastric adenocarcinoma 0 trials
-
Mucinous pancreas adenocarcinoma 0 trials
Most studied deeper sub-types
-
Can Direct-to-Abdomen chemotherapy tame GI cancers that spread?
Disease control Recruiting nowThis phase II trial tests whether adding paclitaxel directly into the abdomen, alongside standard systemic chemotherapy, is feasible for people with gastrointestinal cancers that have spread to the peritoneal lining. The study includes patients with gastric, colorectal, appendice…
Phase 2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Experimental shot takes aim at stomach cancer spread
Disease control Recruiting nowThis early-stage trial tests a drug called ACM-CpG, which is injected directly into the abdomen to stimulate the immune system against cancer. It includes 24 adults with colorectal or appendix cancer that has spread to the lining of the abdomen or caused fluid buildup. The main g…
Phase 1 • Sponsor: Brown University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could Once-Daily radiation replace Twice-Daily for breast cancer recurrence?
Disease control Recruiting nowThis study is for women whose breast cancer has come back after initial breast-conserving surgery and whole breast radiation. The standard treatment after repeat surgery is radiation twice a day for 30 sessions. This trial tests whether giving radiation once a day for 15 sessions…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for rare appendix cancer: targeted chemotherapy delivered straight to the belly
Disease control Recruiting nowThis study tests a chemotherapy drug called paclitaxel, given directly into the abdominal cavity, for people with appendix cancer that has spread. The goal is to find a safe dose and see if it helps control the disease. About 39 adults with advanced appendix cancer that cannot be…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Blood test could personalize chemo for gut cancer patients
Disease control Recruiting nowThis study is testing whether a simple blood test that measures tumor DNA (ctDNA) can help doctors decide how much chemotherapy to give before surgery for colorectal or appendix cancer that has spread to the abdomen. The goal is to see if the test can identify patients who need s…
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Patient stories could unlock new treatments for rare appendix cancer
Knowledge-focused Recruiting nowThis study is building a global patient registry to collect real-world information from people diagnosed with appendix cancer or pseudomyxoma peritonei (PMP), a rare condition where tumors spread in the abdomen. Participants and caregivers share details about their symptoms, trea…
Sponsor: Appendix Cancer Pseudomyxoma Peritonei Research Foundation • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Scientists dig into DNA of rare gut cancer to improve prognosis
Knowledge-focused Recruiting nowThis study looks at stored tumor samples from 400 people with appendiceal cancer. Researchers will analyze DNA and RNA modifications to find patterns linked to how the cancer behaves. The goal is to create a molecular score that could one day help doctors predict outcomes more ac…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC